ELSA Studies studies progression of atherosclerosis. Calcium antagonist arrests the process more than a beta-blocker
Einecke, D.
MMW Fortschritte der Medizin 143(26-27): 6
2001
ISSN/ISBN: 1438-3276 PMID: 11481923 Document Number: 533314
Document emailed within 1 workday
Related Documents
Eigenmann, R.; Blaber, L.; Nakamura, K.; Thorens, S.; Haeusler, G. 1981: Tiapamil, a new calcium antagonist. 1. Demonstration of calcium antagonistic activity and related studies Arzneimittel-Forschung 31(9): 1393-1401Guarneri, L.; Angelico, P.; Ibba, M.; Poggesi, E.; Taddei, C.; Leonardi, A.; Testa, R. 1996: Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine Arzneimittel-Forschung 46(1): 15-24
Kawanishi, D.T.; Reid, C.L.; Gonzales, A.; O'Rourke, R.A.; Rahimtoola, S.H. 1989: Response of blood pressure, cardiac output, peripheral resistance, and exercise performance to substitution of calcium blocker for beta-blocker plus thiazide diuretic therapy in patients with both systemic hypertension and mild stable angina Circulation 80(6 Suppl): Iv162-Iv170
Klieber, M.; Resch, F. 1986: Comparative studies of the effect of a cardioselective and a noncardioselective beta-blocker on peripheral circulation in patients with arterial occlusive disease Wiener Klinische Wochenschrift 98(3): 70-73
Walter, I.; Kusus, T.; Wagner, K.; Lydtin, H. 1973: Effect of a beta receptor blocker on cardiac output--studies in essential hypertension and hyperkinetic heart syndrome with reference to plasma adrenaline and noradrenaline levels Verhandlungen der Deutschen Gesellschaft für Innere Medizin 79: 1010-1013
Furberg, C.D.; Byington, R.P. 1983: What do subgroup analyses reveal about differential response to beta-blocker therapy? The Beta-Blocker Heart Attack Trial experience Circulation 67(6 Part 2): I98-101
Toyoda, K.; Kitahara, M.; Yamashita, T.; Shudo, C.; Masuda, Y.; Sakashita, M.; Tanaka, S.; Saito, Y. 1994: Effect of efonidipine hydrochloride (NZ-105), a new dihydropyridine calcium antagonist, on the experimental atherosclerosis in cholesterol-fed rabbits Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 103(5): 231-239
Löllgen, H.; Schmidt, A.; Upmeyer, H.J. 1986: Double-blind comparison of fixed combination preparations of a beta blocker and a diuretic and beta blocker, a diuretic and hydralazine in patients with coronary heart disease and arterial hypertension Medizinische Klinik 81(23): 745-750
Ueda, M.; Masui, M.; Kawakami, M.; Matsunaga, K.; Gemba, T.; Ninomiya, M.; Nakano, A.; Torii, M.; Adachi, I.; Ito, H. 1993: Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 4th communication: prophylactic and therapeutic effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3- b]pyridine-5-carboxylate in stroke-prone spontaneously hypertensive rats Arzneimittel-Forschung 43(12): 1291-1303
Metelitsa, V.I.; Slastnikova, I.D.; Martsevich, S.I. 1985: Screening of single doses of nitrates, calcium antagonists and beta-adrenoblockaders in patients with stenocardia of effort by using pharmacodynamic treadmill studies Terapevticheskii Arkhiv 57(11): 126-130
Nakajima, M.; Adachi, I.; Ueda, M. 1993: Pharmacological studies on a new Dihydrothienopyridine calcium antagonist. 2nd communication: effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4- (3-nitrophenyl)thieno[2,3-b]pyridine-5-carboxylate on the 1,4-dihydropyridine binding sites in the brain and on isolated arteries in the Cynomolgus monkey Arzneimittel-Forschung 43(12): 1276-1282
Aoki, K.; Sato, K. 1982: Acute hypotensive, hemodynamic effects of long-term treatment with niludipine, a Ca2+-antagonist, in patients with essential hypertension. Niludipine monotherapy and combination with a beta-blocker and a diuretic) Arzneimittel-Forschung 32(9): 1141-1145
Iwata, S.; Miyauchi, S. 1985: Biochemical studies on the use of sodium hyaluronate in the anterior eye segment. III. Histological studies on distribution and efflux process of 5-aminofluorescein-labeled hyaluronate Japanese Journal of Ophthalmology 29(2): 187-197
Kido, H.; Uchida, Y.; Nakamura, F.; Sugimoto, T. 1990: Angiographic studies on the effects of a novel calcium antagonist AE0047 on cerebral arteries in dogs, with special reference to the preventive effects of AE0047 on cerebral vasoconstriction induced by endothelin Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 95(4): 177-184
Alexanian, A.R.; Arutyunian, N.S.; Galoyan, A.A. 1996: Antiarrhythmic action of the new calcium antagonist [1,2,5-trimethyl-4-phenyl-4-beta-(N-cyanoethyl-N-4'-methoxybenzyl) -ethylamino]piperidine dihydrochloride Arzneimittel-Forschung 46(12): 1110-1113
Shmidt, I.; Khomut, V.; Monike, V.; Bakh, K.; Fliugel', K. 1985: Central and peripheral hemodynamics during combined treatment of arterial hypertension with calcium antagonist nifedipine and beta-adrenergic blockader talinolol Kardiologiia 25(6): 110-111
Yamazaki, R.K.; Mickey, D.L.; Story, M. 1979: The calibration and use of a calcium ion-specific electrode for kinetic studies of mitochondrial calcium transport Analytical Biochemistry 93(2): 430-441
Rasmussen, L.H.; Husted, S.E.; Clemmensen, P.M.; Gøtzsche, C.O.; Helqvist, S.; Kristensen, S.D.; Pedersen, K.E.; Rasmussen, K.; Rasmussen, S. 2000: Clinical studies on glycoprotein IIb/IIIa receptor antagonist Ugeskrift for Laeger 162(44): 5944-5947
Möhlenkamp, S.; Schmermund, A.; Budde, T.; Erbel, R. 2007: Current studies on the progression of coronary calcification MMW Fortschritte der Medizin 149(27-28 Suppl): 75-84
Fawzi, W.; Msamanga, G.; Spiegelman, D.; Hunter, D.J. 2005: Studies of vitamins and minerals and HIV transmission and disease progression Journal of Nutrition 135(4): 938-944